Epitope mapping of anti-drug antibodies to a clinical candidate bispecific antibody
Anti-drug antibodies (ADA) can limit the efficacy and safety of therapeutic antibodies. However, determining the exact nature of ADA interactions with the target drug via epitope mapping is challenging due to the polyclonal nature of the IgG response. Here, we demonstrate successful proof-of-concept...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Journal Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2022-12-01
|
| Series: | mAbs |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/19420862.2022.2028337 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|